ATMO® Risk Report

🏗️ Operational & Business Continuity

Atmo® is actively participating in diverse operations and technological developments, ensuring its business continuity and operational efficiency. Key activities indicate a focus on innovation which may enhance its market position and resilience against potential operational risks.

• Atmo collaborated with Rainmaker to enhance cloud seeding techniques, aiming to increase rainfall, reported 🗓 July 15, 2025.
• A new Turkish factory by a Chinese automaker associated with Atmo is projected to produce 20,000 cars annually from 🗓 July 14, 2025.
• The Atmo Capsule, designed for gastrointestinal transit assessment, shows potential to replace the Smartpill capsule according to a study comparison published 🗓 January 30, 2025.
• On 🗓 January 27, 2025, Atmo's partnership with Mago expanded environmental air quality monitoring with six new data sets, showcasing a strategic expansion of capabilities.

📜 Innovation & R&D

Atmo®'s innovation efforts have been shown through its involvement with cutting-edge technologies and partnerships. These activities suggest a strong focus on R&D, vital for future growth and competitive advantage.

• Atmo's aerially transforming Morphobot for dynamic ground-aerial transition was featured in Nature 🗓 April 19, 2025, highlighting significant advancements in robotics.
• Atmo Biosciences received US FDA clearance for its ingestible gas-sensing capsule 🗓 June 30, 2025, indicating regulatory success in product development.
• Caltech's development of a drone capable of transitioning smoothly from flight to ground movement was shared on 🗓 May 28, 2025.